|
Capabilities & Affiliations |
|
Core Capabilities for Accelerated Drug Development Lipitek International Well-equipped research labs for chemical synthesis and biological evaluations; GMP manufacturing suite UT Health Science Center (Prof. Luduena) Biological evaluation and testing of new anti-mitotics, including tubulin isotype-specific assays University of Alberta (Prof. Tuszynski) Molecular modeling, computer simulation of new molecules, molecule design and in silico screening AAI Oncology (Paris) Global oncology-focused clinical Contract Research Organization (CRO) Cancer Therapy & Research Center (CTRC)/Institute for Drug Development (IDD) In vitro and in vivo capabilities; Phase I/II clinical trials Other Local Resources Southwest Oncology Group Southwest Foundation for Biomedical Research |